Target intelligence / Profile preview

HIG1 hypoxia inducible domain family member 1A pseudogene 11 (HIGD1AP11)

Target
HIGD1AP11
Molecular classification
Pseudogene
01

Overview

HIGD1AP11 is a pseudogene belonging to the HIG1 hypoxia inducible domain family. It is not capable of encoding a functional protein and thus does not act as a therapeutic target. Pseudogenes can sometimes influence gene expression through non-coding RNA, but specific roles for HIGD1AP11 are not well-documented.

Other names
HIG1 hypoxia inducible domain family member 1A pseudogene 11

Beyond the preview

Go deeper on HIG1 hypoxia inducible domain family member 1A pseudogene 11 (HIGD1AP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 11 (HIGD1AP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call